title: Effect of anabolic steroids on mitochondria and sarcotubular system of skeletal muscle.
abstract: Soleus and extensor digitorum longus (EDL) mitochondria and sarcotubular system were examined in sedentary and trained (treadmill for 12 wk) male rats that were treated with fluoxymesterone or methandrostanolone (2 mg/kg, 5 days/wk, for 8 wk). Neither physical exercise nor anabolic/androgenic steroid administration resulted in a significant change in muscle wet weight. Treatment with the anabolizing androgens increased succinate dehydrogenase activity in fast-twitch muscle mitochondria; this effect was not enhanced by training and was not observed in soleus mitochondria. On the other hand, the content of the slow-twitch muscle in sarcotubular fraction was increased in sedentary rats by fluoxymesterone or methandrostanolone treatment, whereas no significant changes were found in EDL. The training program affected adenosinetriphosphatase (ATPase) activities in the sarcotubular fraction; Mg2(+)-ATPase was increased in both soleus and EDL, but Ca2(+)-ATPase was decreased only in soleus. However, in sedentary animals only the Mg2(+)-dependent activity of EDL was increased by anabolizing androgen treatment, and this change was not potentiated by additional training. The present data indicate that anabolic/androgenic steroids can affect mitochondrial and sarcotubular enzymes in skeletal muscle. The effects are muscle-type specific.
authors.affiliation: Department of Biochemistry and Molecular Biology I, Faculty of Chemistry, Complutense University, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Saborido
authors.forename: J
authors.initials: J
authors.lastname: Vila
authors.forename: F
authors.initials: F
authors.lastname: Molano
authors.forename: A
authors.initials: A
authors.lastname: Megías
mesh_terms: D045930:Anabolic Agents / Q000494:pharmacology*; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase / Q000378:metabolism; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D005474:Fluoxymesterone / Q000494:pharmacology; D008297:Male; D008696:Methandrostenolone / Q000494:pharmacology; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000201:enzymology; D009132:Muscles / Q000187:drug effects* / Q000201:enzymology; D010805:Physical Conditioning, Animal; D051381:Rats; D011919:Rats, Inbred Strains; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology; D013385:Succinate Dehydrogenase / Q000378:metabolism
chemical_list: D045930:Anabolic Agents; D005474:Fluoxymesterone; D008696:Methandrostenolone; D013385:Succinate Dehydrogenase; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases